March 5, 2008 by Joe Ponzio

In late July, I posted an analysis of Amylin Pharmaceuticals (AMLN) that was not exactly a favorite of Michael’s. I figured that my response belonged in a post rather than in the comments because it was more of a “noise vs. news” debate, and Michael responded in turn with some…

» Read this article

September 13, 2007 by Joe Ponzio

Analyzing companies is fairly straightforward. Finding companies to analyze is a different ballgame. In the U.S. alone, there are more than 10,000 publicly traded companies. With the power of the internet, we can now invest worldwide-bringing the number of available investment options to staggering proportions. Let’s narrow it down a…

» Read this article